|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
1838812 |
| 005 |
20030520052900.0 |
| 008 |
950809s1995 nyu b 101 0 eng c |
| 003 |
ICU |
| 010 |
|
|
|a 95017469
|
| 020 |
|
|
|a 0897668626 (cloth : alk. paper)
|
| 020 |
|
|
|a 0897668634 (pbk. : alk. paper)
|
| 035 |
|
|
|a (ICU)BID21041012
|
| 035 |
|
|
|a (OCoLC)32509365
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d ICU
|d OrLoB-B
|d OCoLC
|
| 041 |
0 |
|
|a eng
|
| 050 |
0 |
0 |
|a Q11
|b .N5 vol. 754
|a RM281
|
| 060 |
|
0 |
|a W1 AN626YL v. 754 1995
|a QW 805 C731 1995
|
| 082 |
0 |
0 |
|a 500 s
|a 615/.372
|2 20
|
| 245 |
0 |
0 |
|a Combined vaccines and simultaneous administration :
|b current issues and perspectives /
|c edited by Jim C. Williams ... [et al.].
|
| 260 |
|
|
|a New York, N.Y. :
|b New York Academy of Sciences,
|c 1995.
|
| 263 |
|
|
|a 9506
|
| 300 |
|
|
|a xv, 404 p. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Annals of the New York Academy of Sciences
|v v. 754
|
| 500 |
|
|
|a Based on a conference sponsored by the Center for Biologics Evaluation and Research, et al., on July 28-30, 1993 in Bethesda, Md.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Overview - Combination Vaccines and Simultaneous Administration: Past, Present, and Future /
|r Karen L. Goldenthal, Drusilla L. Burns, Loris D. McVittie, Benjamin P. Lewis, Jr. and Jim C. Williams --
|t Combined and Simultaneously Administered Vaccines: A Brief History /
|r Paul D. Parkman --
|t FDA Perspective on Regulatory Issues in Vaccine Development /
|r Bascom F. Anthony --
|t Strategies for Developing Combination Vaccines /
|r Ronald J. Saldarini --
|t Manufacturing Issues for Multivalent Vaccines /
|r Arthur Y. Elliott --
|t Combination Vaccines: Regulatory Issues /
|r D. K. McClintock --
|t Potential Alterations in Immunogenicity by Combining or Simultaneously Administering Vaccine Components /
|r Richard A. Insel --
|t Determinant Flanking Regions and the Design of Appropriate Vaccines /
|r Luis Soares, Hongkui Deng, Iqbal S. Grewal, Vipin Kumar, Alexander Miller, Kamal D. Moudgil, Mark Palmer and Eli E. Sercarz --
|t Selection of Carrier and B Cell Protectope Sequences for Vaccines /
|r Howard M. Etlinger --
|t Prevention of Systemic Infections Caused by Group B Streptococcus and Staphylococcus aureus by Multivalent Polysaccharide-Protein Conjugate Vaccines /
|r John B. Robbins, Rachel Schneerson, Willie F. Vann, Dolores A. Bryla and Ali Fattom --
|t Definition and Clinical Assessment of Consistency Lots for Combination Vaccines /
|r Bernard Fritzell --
|t Immune Responses to Pertussis Vaccines Concurrently Administered with Viral Vaccines /
|r Scott A. Halperin, Brian J. Eastwood and Joanne M. Langley --
|t Comparative Evaluation of Immunization with Live Attenuated and Inactivated Poliovirus Vaccines /
|r Pearay L. Ogra --
|t Combination Vaccines for Diphtheria, Tetanus, Pertussis, and Haemophilus influenzae Type b /
|r Peter R. Paradiso --
|t The Biochemistry and Cell Biology of Antigen Presentation by MHC Class I and Class II Molecules: Implications for Development of Combination Vaccines /
|r Ronald N. Germain --
|t Vaccine Strategies: Targeting Helper T Cell Responses /
|r Basil Golding and Dorothy E. Scott --
|t The Role of sIgA + B Cells in Oral Immunity /
|r Rolf O. Ehrhardt and Warren Strober --
|t Liposomal Vaccines: Clinical Status and Immunological Presentation for Humoral and Cellular Immunity /
|r Carl R. Alving --
|t Immunologic Adjuvants for Modern Vaccine Formulations /
|r Frederick R. Vogel --
|t Designing Peptide Vaccines to Broaden Recognition and Enhance Potency /
|r Jay A. Berzofsky --
|t Galactose Oxidation as a Potent Vaccine Adjuvant Strategy: Efficacy in Murine Models and in Protection against a Bovine Parasitic Infection /
|r John Rhodes, Biao Zheng and Christopher A. Morrison --
|t The Hepatitis Nucleocapsid as a Vaccine Carrier Moiety /
|r D. R. Milich, D. L. Peterson, J. Zheng, J. L. Hughes, R. Wirtz and F. Schodel --
|t Yeast Retrotransposon Particles as Antigen Delivery Systems /
|r Alan J. Kingsman, Nigel R. Burns, Guy T. Layton and Sally E. Adams --
|t Progress on Development of the Live BCG Recombinant Vaccine Vehicle for Combined Vaccine Delivery /
|r Mark S. Hanson, Claudia Vigil Lapcevich and Shirley L. Haun --
|t Live Attenuated Vaccinia and Other Poxviruses as Delivery Systems: Public Health Issues /
|r Marion E. Perkus, Jill Taylor, James Tartaglia, Steven Pincus, Elizabeth B. Kauffman, John A. Tine and Enzo Paoletti --
|t Issues in Design of Clinical Trials of Combination Vaccines /
|r Michael D. Decker and Kathryn M. Edwards --
|t Industry Perspective on Clinical Trial Issues for Combination Vaccines /
|r Kenneth R. Brown --
|t Practical Considerations Regarding the Impact on Immunization Schedules of the Introduction of New Combined Vaccines /
|r Neal A. Halsey --
|t Interactions between PRP-T Vaccine against Haemophilus influenzae Type b and Conventional Infant Vaccines: Lessons for Future Studies of Simultaneous Immunization and Combined Vaccines /
|r John Clemens, Ruth Brenner and Malla Rao --
|t International Prospects for Combined Vaccines with Emphasis on Quadrivalent Diphtheria-Tetanus-Pertussis-Hepatitis B Vaccine /
|r Joseph L. Melnick --
|t Defining Surrogate Serologic Tests with Respect to Predicting Protective Vaccine Efficacy: Pertussis Vaccination /
|r Patrick Olin --
|t Laboratory Correlates of Protection against Haemophilus influenzae Type b Disease: Importance of Assessment of Antibody Avidity and Immunologic Memory /
|r Dan M. Granoff and Alexander H. Lucas --
|t Defining Surrogate Serologic Tests with Respect to Predicting Protective Vaccine Efficacy: Poliovirus Vaccination /
|r Roland W. Sutter, Mark A. Pallansch, Leigh A. Sawyer, Stephen L. Cochi and Stephen C. Hadler --
|t Methodological Issues in the Evaluation and Monitoring of Vaccine Safety /
|r Paul E. M. Fine --
|t Surveillance of the Safety of Simultaneous Administration of Vaccines: The Centers for Disease Control and Prevention Experience /
|r Robert T. Chen, Penina Haber and John R. Mullen --
|t Similarity/Equivalence Trials for Combination Vaccines /
|r William C. Blackwelder --
|t The Statistical Analysis of Immunogenicity Data in Vaccine Trials: A Review of Methodologies and Issues /
|r Amelia Dale Horne --
|t Combination Live Enteric Virus Vaccines /
|r Samuel L. Katz --
|t Combination Live Respiratory Virus Vaccines /
|r Mary Lou Clements --
|t Progress and Challenges for a New Combination Vaccine Composed of Diphtheria, Tetanus, Acellular Pertussis, and Haemophilus b Conjugate /
|r Dace V. Madore --
|t Surrogate Serologic Tests for the Prediction of Pertussis Vaccine Efficacy /
|r James D. Cherry, Ulrich Heininger, Peter D. Christenson, Thomas Eckhardt, Suzanne Laussucq, Jill G. Hackell, Joseph R. Mezzatesta and Klemens Stehr --
|t Comprehensive Evaluation of Vaccine Safety: Assessment of Local and Systemic Side Effects as well as Emergency and Hospital Utilization /
|r Steven Black and Henry Shinefield --
|t Vaccine Licensure: A Proposal to Meet Changing Needs /
|r Frederick C. Robbins and Edward A. Mortimer, Jr. --
|t Utility of Large-linked Databases in Vaccine Safety, Particularly in Distinguishing Independent and Synergistic Effects /
|r Steven G. F. Wassilak, John W. Glasser, Robert T. Chen and Stephen C. Hadler /
|r Vaccine Safety Datalink Investigators --
|t Combination Vaccines: Some Practical Considerations /
|r Robert S. Daum, Anjali Jain and Karen P. Goldstein --
|t Summary: A Perspective on Issues Relating to Future Vaccines /
|r Barry R. Bloom.
|
| 650 |
|
0 |
|a Vaccines
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2010117638
|
| 650 |
|
0 |
|a Vaccination
|v Congresses.
|
| 650 |
1 |
2 |
|a Vaccines, Combined
|x administration & dosage
|v Congresses.
|
| 650 |
1 |
2 |
|a Vaccines, Combined
|x pharmacology
|v Congresses.
|
| 650 |
2 |
2 |
|a Drug Design
|v congresses.
|
| 650 |
|
2 |
|a Drug Delivery Systems
|v Congresses.
|
| 650 |
|
2 |
|a Drug Evaluation
|v congresses.
|
| 650 |
|
7 |
|a Vaccination.
|2 fast
|0 http://id.worldcat.org/fast/fst01163544
|
| 650 |
|
7 |
|a Vaccines.
|2 fast
|0 http://id.worldcat.org/fast/fst01163573
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
|
|a Williams, Jim C.
|0 http://id.loc.gov/authorities/names/n89108313
|1 http://viaf.org/viaf/59234256
|
| 710 |
2 |
|
|a Center for Biologics Evaluation and Research (U.S.)
|0 http://id.loc.gov/authorities/names/n88098944
|1 http://viaf.org/viaf/125284200
|
| 901 |
|
|
|a ToCBNA
|a Analytic
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i ac75d415-2ce5-50fa-adbf-19fef79e8bbf
|s 5504ee03-353e-5404-815f-dc463b4e607a
|
| 928 |
|
|
|t Library of Congress classification
|a Q11.N5 v.754
|l ASR
|c ASR-SciASR
|i 2605745
|
| 927 |
|
|
|t Library of Congress classification
|a Q11.N5 v.754
|l ASR
|c ASR-SciASR
|g Analytic
|e CRERAR
|b A42718990
|i 3379018
|
